China April industrial profits +14.0 pct y/y - stats bureau
BEIJING, May 27 Profits earned by China’s industrial firms in April rose 14.0 percent from a year earlier, the statistics bureau said on Saturday, slowing from the pace in March.
MUMBAI, April 10 India's Natco Pharma Ltd has formally asked the Indian patent office to deny U.S. drugmaker Gilead Sciences Inc's breakthrough hepatitis C drug Sovaldi a patent in India, a source with direct knowledge of the matter said.
If successful, the move could clear the way for the Indian company to launch a generic version of the drug.
Natco has filed a so-called "pre-grant opposition" with India's Controller General of Patents, Designs & Trademarks, said the source, who declined to be named because the information was not public yet.
Reuters could not immediately obtain a copy of the filing.
Natco Chief Executive Rajeev Nannapaneni declined to comment. Officials at the Indian patent department in Mumbai were not immediately available for comment.
India's patent laws allow a third party to dispute the validity of a pending patent application. Natco has opposed the patent on the grounds that Sovaldi is not "inventive" enough, the source said.
Foster City, California,-based Gilead aims to license Sovaldi to three or four Indian generic manufacturers to allow sale of the medicine at lower prices in some 60 developing nations including India. (Reporting by Zeba Siddiqui in MUMBAI; Editing by Tony Munroe)
May 26 Hackers used malware to steal customer payment data from most of Chipotle Mexican Grill Inc's restaurants over a span of three weeks, the company said on Friday, adding to woes at the chain whose sales had just started recovering from a string of food safety lapses in 2015.
* Receives final order approving proposed plan of arrangement with WI-LAN